TY  - JOUR
AU  - Doello, Kevin
AU  - Quinonero, Francisco J.
AU  - Perazzoli, Gloria
AU  - Gago, Lidia
AU  - Chico, Mari Angeles
AU  - Mesas, Cristina
PY  - 2021
DO  - 10.30827/ars.v63i1.22390
SN  - 0004-2927
UR  - http://hdl.handle.net/10668/21803
T2  - Ars pharmaceutica
AB  - Introduction: Pancreatic cancer treatment in advanced stages is based on different chemotherapy regimens. Cancer stem cells are responsible for tumor chemoresistance and recurrence in adjuvant and metastatic settings. The objective of this article was...
LA  - en
PB  - Univ granada, editorial
KW  - Pancreatic cancer
KW  - cancer stem cells
KW  - chemoresistance
KW  - chemotherapeutic protocols
KW  - personalized therapy
KW  - Adenocarcinoma
KW  - Resistance
KW  - Pancreatic Neoplasms
KW  - Irinotecan
KW  - Gemcitabine
KW  - IFL protocol
KW  - Albumin-Bound Paclitaxel
KW  - Oxaliplatin
KW  - Adenocarcinoma
KW  - Drug Resistance, Neoplasm
KW  - Fluorouracil
KW  - Neoplastic Stem Cells
KW  - Cell Line
TI  - Citotoxicidad diferencial según el régimen de quimioterapia contra las células madre del cáncer de páncreas: estudio preliminar in vitro
T2  - Differential chemotherapeutic regimen cytotoxicity against pancreatic cancer stem cells: a preliminary in vitro study
TY  - research article
VL  - 63
ER  -